Study Stirs Doubts On Phenylephrine, Questions On Monograph Process

Researchers say “an optimal dose of PE that is safe and produces clinically significant decongestion is still unknown,” and advocates for removing phenylephrine from the OTC monograph say their study is the proof FDA requested.

More from United States

More from North America